| Direct Competitor Comparison | |
|---|
| SGEN | IMGN | PVT1 | PFE | Industry |
|---|
| Market Cap: | 4.26B | 1.47B | N/A | 206.41B | 71.76B |
|---|
| Employees: | 538 | 245 | N/A | 89,400 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.19 | 6.69 | N/A | -0.09 | 0.27 |
|---|
| Revenue (ttm):
| 219.90M | 34.66M | N/A | 57.60B | 13.93B |
|---|
| Gross Margin (ttm): | 0.12 | -1.49 | N/A | 0.81 | 0.72 |
|---|
| EBITDA (ttm): | -51.75M | -68.70M | N/A | 25.34B | 1.51B |
|---|
| Operating Margin (ttm):
| -0.26 | -2.12 | N/A | 0.32 | 0.13 |
|---|
| Net Income (ttm): | -57.75M | -73.35M | N/A | 10.52B | N/A |
|---|
| EPS (ttm): | -0.49 | -0.89 | N/A | 2.09 | 0.61 |
|---|
| P/E (ttm): | N/A | N/A | N/A | 13.93 | 18.43 |
|---|
| PEG (5 yr expected): | N/A | N/A | N/A | 4.78 | 1.51 |
|---|
| P/S (ttm): | 19.38 | 41.54 | N/A | 3.61 | 3.64 |
|---|
|
| IMGN = ImmunoGen, Inc. | | Pvt1 = Novartis Corporation (privately held) | | PFE = Pfizer Inc. | | Industry = Biotechnology | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.41 | 0.01 | 79.25B | 17.84 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 233.85 | 0.00 | 55.52B | 37.11 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 55.71 | -0.00 | 84.92B | 31.19 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 74.01 | -0.00 | 12.73B | 31.33 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.21 | -0.00 | 33.44B | 19.58 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 128.82 | -0.01 | 16.45B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.55 | -0.00 | 12.03B | 21.07 |
|---|
| Pfizer Inc. | PFE | 29.11 | -0.01 | 206.41B | 13.93 |
|---|
| Johnson & Johnson | JNJ | 87.59 | -0.00 | 245.97B | 23.79 |
|---|
| GlaxoSmithKline plc | GSK | 52.58 | -0.01 | 127.54B | 19.22 |
|---|
| Sanofi | SNY | 54.76 | -0.01 | 145.60B | 26.99 |
|---|
| Novartis AG | NVS | 73.74 | -0.01 | 181.44B | 18.72 |
|---|
| Roche Holding AG | RHHBY | 64.78 | -0.01 | 219.86B | 21.68 |
|---|
| AstraZeneca PLC | AZN | 51.80 | -0.01 | 64.92B | 11.46 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.50 | -0.01 | 58.57B | 11.43 |
|---|
| Bristol-Myers Squibb Company | BMY | 46.56 | 0.00 | 76.58B | 52.73 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
1.77%